Sitting down with Rakesh Gunti, the poised CEO of France’s Rayshigh Information Technology, one is immediately struck by a sense of intentional foresight. Our conversation wasn’t merely about achievements, but about preparation—the deliberate groundwork for a revolution still unfolding. At its heart lies his ongoing journey toward a PhD in Quantum Computing, a scholarly pursuit that is far from academic. It is, instead, the active blueprint for a new vision of healthcare. Gunti describes this deep dive into quantum theory not as a detour from his corporate role, but as its essential foundation. “To build the future, you must first learn its native language,”  he explains, his focus sharp. His research into qubits, superposition, and entanglement is a meticulous preparation. He is decoding the fundamental code of nature itself, understanding that the human body—its proteins, its diseases, its very chemistry—operates on this subatomic scale. For Gunti, the PhD is the ultimate R&D, equipping him to ask the questions that haven’t yet been formulated. This preparatory work is already catalysing tangible innovation at Rayshigh through what he term “ I-technology” —Intuitive, Integrated, and Intelligent systems. His collaborations with leading medical companies are the practical canvas for his theoretical insights. He is architecting platforms where quantum-inspired algorithms can one day simulate drug interactions with breathtaking biological accuracy, and where AI, refined by quantum logic, moves from retrospective analysis to proactive prediction. “We are preparing for a paradigm of precision where medicine is not reactive, but anticipatory,” Gunti states, his words bridging the gap between lab and life. His style is a compelling synthesis: the strategic calm of a CEO fused with the inquisitive energy of a scholar on the verge of discovery. He leads not from a place of assured dogma, but from one of purposeful exploration. Rakesh Gunti is, therefore, more than an executive. He is a futurist in preparation. While others chase the immediate application, he is mastering the core principles that will define the next epoch. His PhD is the keystone, and his “I-technology” is the bridge being built from that knowledge toward a world where healthcare is profoundly personalized, intelligent, and inherently humane. The future of medicine is being written, and Gunti is meticulously preparing its most vital chapter.